Battery Ventures, a technology-focused investment firm, completed the acquisition of a majority stake in Titian Software, a company that develops innovative sample-management software. Financial terms were not disclosed. “The broader life-sciences sample-management market is poised for more growth, with trends such as personalized medicine and genomic sequencing driving more high-throughput, lab screening, as well as the creation of new labs to support this activity. All of this will drive growth at Titian," Jesse Feldman, Battery General Partner.